Diagnosis of bone metastasis: recent comparative studies of imaging modalities.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The Quarterly Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 21738113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.

  2011cited by this paper
• Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

  2011cited by this paper
• A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer

  2011cited by this paper
• Diagnostik und Therapie von Wirbelsäulenmetastasen

  2011cited by this paper
• Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.

  2011cited by this paper
• Comparison of [111In]pentetreotide‐SPECT and [18F]FDOPA‐PET in the localization of extra‐adrenal paragangliomas: the case for a patient‐tailored use of nuclear imaging modalities

  2011cited by this paper
• Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain

  2010cited by this paper
• Estimates of cancer incidence and mortality in Europe in 2008.

  2010cited by this paper
• 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

  2010cited by this paper
• 18F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging

  2010cited by this paper
• A meta-analysis of 18F-Fluoride positron emission tomography for assessment of metastatic bone tumor

  2010cited by this paper
• Comparison of 18F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients

  2010cited by this paper
• Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of 18F-Fluorocholine and 18F-FDG in Patients with Cirrhosis or Chronic Liver Disease

  2010cited by this paper
• Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging

  2010cited by this paper
• ACR appropriateness criteria on metastatic bone disease.

  2010cited by this paper
• Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma

  2010cited by this paper
• Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.

  2010cited by this paper
• Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.

  2010cited by this paper
• Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma

  2010cited by this paper
• The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

  2010cited by this paper
• 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

  2010cited by this paper
• The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy

  2010cited by this paper
• Clinical Value of 18-Fluorine-Fluorodihydroxyphenylalanine Positron Emission Tomography/Computed Tomography in the Follow-Up of Medullary Thyroid Carcinoma

  2010cited by this paper
• 18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer

  2010cited by this paper
• 18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT

  2010cited by this paper
• Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.

  2010cited by this paper
• Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.

  2010cited by this paper
• The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients

  2010cited by this paper
• Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)

  2010cited by this paper
• The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT

  2010cited by this paper
• Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).

  2010cited by this paper
• Usefulness 18F‐FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients

  2010cited by this paper
• Bone metastases from renal cell carcinoma: patient survival after surgical treatment

  2010cited by this paper
• When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.

  2010cited by this paper
• WHAT IS THE SIGNIFICANCE OF SOLITARY BONY ABNORMALITIES ON BONE SCINTIGRAMS OF CHILDREN WITH MALIGNANCY?

  2010cited by this paper
• Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?

  2010cited by this paper
• Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.

  2010cited by this paper
• Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.

  2010cited by this paper
• Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.

  2010cited by this paper
• Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer.

  2010cited by this paper
• 18F-Fluorodeoxyglucose-PET for Patients With Suspected Spondylitis Showing Modic Change

  2010cited by this paper
• Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance

  2009cited by this paper
• Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

  2009cited by this paper
• 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma

  2009cited by this paper
• Improved Classifications of Planar Whole-Body Bone Scans Using a Computer-Assisted Diagnosis System: A Multicenter, Multiple-Reader, Multiple-Case Study

  2009cited by this paper
• Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

  2009cited by this paper
• Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up

  2009cited by this paper
• Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

  2009cited by this paper
• Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study

  2009cited by this paper
• The effectiveness of 124I PET/CT in patients with differentiated thyroid cancer.

  2009cited by this paper
• Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma

  2009cited by this paper
• Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy

  2009cited by this paper
• Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia

  2009cited by this paper
• Urinary calculi: radiation dose reduction of 50% and 75% at CT--effect on sensitivity.

  2009cited by this paper
• Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.

  2009cited by this paper
• Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.

  2009cited by this paper
• Disseminated Tumor Cells in Bone Marrow May Affect Prognosis of Patients With Gynecologic Malignancies

  2009cited by this paper
• Multimodality imaging: beyond PET/CT and SPECT/CT.

  2009cited by this paper
• Whole‐body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer

  2009cited by this paper
• A look ahead: PET/MR versus PET/CT

  2009cited by this paper
• Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression

  2009cited by this paper
• The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT

  2009cited by this paper
• Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT

  2009cited by this paper
• Detection of hematogenous bone metastasis in cervical cancer

  2009cited by this paper
• Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.

  2009cited by this paper
• Primary tumor resection improves the survival of younger patients with metastatic breast cancer.

  2009cited by this paper
• Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?

  2009cited by this paper
• Significance of 18F‐fluorodeoxyglucose positron‐emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma

  2009cited by this paper
• Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.

  2008cited by this paper
• A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma

  2008cited by this paper
• The implication of hot spots on bone scans within the irradiated field of breast cancer patients treated with mastectomy followed by radiotherapy

  2008cited by this paper
• Bone metastases from differentiated thyroid carcinoma.

  2008cited by this paper
• Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study

  2008cited by this paper
• Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers

  2008cited by this paper
• Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.

  2008cited by this paper
• Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images

  2008cited by this paper
• Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET

  2008cited by this paper
• Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT

  2008cited by this paper
• Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.

  2008cited by this paper
• Nachweis ossärer Metastasen des Prostatakarzinoms – Vergleich der Leistungsfähigkeit der Ganzkörper-MRT und der Skelettszintigrafie

  2008cited by this paper
• Bone scintigraphy is really unnecessary for evaluation of bone metastasis?

  2008cited by this paper
• Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience

  2008cited by this paper
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy

  2008cited by this paper
• 18F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation

  2008cited by this paper
• 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers

  2008cited by this paper
• Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.

  2008cited by this paper
• Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.

  2008cited by this paper
• Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

  2008cited by this paper
• Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.

  2008cited by this paper
• Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton

  2008cited by this paper
• The diagnostic value of 124I-PET in patients with differentiated thyroid cancer

  2007cited by this paper
• Detection of bone metastases: assessment of integrated FDG PET/CT imaging.

  2007cited by this paper
• Diffusion-Weighted Imaging with Sensitivity Encoding (SENSE) for Detecting Cranial Bone Marrow Metastases: Comparison with T1-Weighted Images

  2007cited by this paper
• 18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma

  2007cited by this paper
• Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy

  2007cited by this paper
• Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.

  2007cited by this paper
• The Use of Radiolabeled Somatostatin Analog Scintigraphy in the Staging of Small Cell Lung Cancer Patients

  2007cited by this paper
• Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement

  2007cited by this paper
• [Clinical usefulness of positron emission tomography in prostate cancer].

  2007cited by this paper
• Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

  2007cited by this paper

• Comparison of 68GA-FAPI-04 PET/CT and 18F-FDG PET/CT in detection of metastatic bone disease in various cancers

  2023cites this paper
• Assessment of bone lesions with 18F-FDG PET/MRI in patients with nasopharyngeal carcinoma

  2023cites this paper
• The use of MRI for the imaging of metastatic bone lesions.

  2023cites this paper
• JOURNAL OF DIAGNOSTIC IMAGING IN THERAPY

  2023cites this paper
• Artificial intelligence in skeletal metastasis imaging

  2023cites this paper
• Review of the role of MRI and 18F-sodium fluoride PET/computed tomography in the characterisation of spinal bone metastases in a cohort of patients with breast cancer

  2022cites this paper
• Artificial Intelligence in Bone Metastases: An MRI and CT Imaging Review

  2022cites this paper
• Diagnostic Performance of CT Compared to PET/CT in Evaluating Bone Metastasis - An Initial Experience from Nepal

  2021cites this paper
• Imaging and its Impact on Defining the Oligometastatic State.

  2021cites this paper
• Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients

  2021cites this paper
• Interim and end-treatment 18F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride

  2021cites this paper
• An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases

  2021cites this paper
• Contribution of pet/mr in muskuloskeletal malignancies.

  2021cites this paper
• PET/MR for evaluation of musculoskeletal malignancies

  2021cites this paper
• Nuclear Medicine Methods in the Diagnosis of Bone Metastases

  2021cites this paper
• ПЭТ/КТ-визуализация рака предстательной железы. Современные варианты радиофармпрепаратов

  2021cites this paper
• Automatic Diagnosis of Coronary Artery Disease in SPECT Myocardial Perfusion Imaging Employing Deep Learning

  2021cites this paper
• Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers

  2021cites this paper
• Development of Convolutional Neural Networkbased models for bone metastasis classification in nuclear medicine

  2020cites this paper
• Solitary Lytic Bone Lesion

  2020cites this paper
• Early bone metastatic dissemination in patient with locally advanced rectal cancer after neoadjuvant chemoradiotherapy

  2020cites this paper
• A Deep-Learning Approach for Diagnosis of Metastatic Breast Cancer in Bones from Whole-Body Scans

  2020cites this paper
• Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues

  2020cites this paper
• 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

  2020cites this paper
• Efficient Bone Metastasis Diagnosis in Bone Scintigraphy Using a Fast Convolutional Neural Network Architecture

  2020cites this paper
• Lymph Node Metastases Detected by PET-CT in Staging and Restaging Exams of Patients with Colon Adenocarcinoma: A Retrospective Study

  2020cites this paper
• Imagerie nucléaire du bilan d’extension du cancer de la prostate

  2019cites this paper
• Comparison of Single Photon Emission Computerised Tomography (SPECT) with Planar Wholebody Bone Scan (WBBS) in Diagnosis of Solitary Vertebral Lesion in Non-Skeletal Malignancies in Terms of Diagnostic Accuracy.

  2019cites this paper
• Radiological Evaluation of the Lumbar Spine

  2019cites this paper
• Protocol-driven multidetector SPECT/CT: integration of hybrid imaging into the routine workflow of whole-body bone scintigraphy in oncology patients.

  2019cites this paper
• Potential Use of Gluconate in Cancer Therapy

  2019cites this paper
• Imagerie du cancer de la prostate oligométastatique, le point de vue du médecin nucléaire

  2019cites this paper
• Evaluation of Skeletal Metastases in Different Clinical Stages of Breast Cancer Patients

  2018cites this paper
• Lésions tumorales rachidiennes secondaires

  2018cites this paper
• PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications.

  2018cites this paper
• Targeted Nanomedicine to Treat Bone Metastasis

  2018cites this paper
• Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure.

  2018cites this paper
• 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study

  2018cites this paper
• Resection of Metastatic Cancer in Castration-Resistant Patients

  2018cites this paper
• Radium-223 in the treatment of bone metastases in patients with castration-resistant prostate cancer. Review and procedure

  2018cites this paper
• Applications of PET‐MRI in musculoskeletal disease

  2018influential citation
• Chemotherapy for oligometastatic prostate cancer

  2017cites this paper
• Diagnostic Imaging Pathways-Bone Metastases

  2017cites this paper
• Quantifying functional imaging modalities and their application in the assessment of treatment response and prognosis in bone metastases

  2017cites this paper
• Knochenmetastasen – Pathophysiologie, Diagnostik und Therapie (Teil 1)

  2017cites this paper
• Scintigraphy and SPECT/CT in Disease of the Spine

  2017cites this paper
• Development of imaging probes for bone cancer in animal models. A systematic review.

  2016cites this paper
• PET/MR Imaging in Musculoskeletal Disorders.

  2016cites this paper
• Wertigkeit der SPECT/CT in der skelettszintigrafischen Diagnostik

  2016cites this paper
• PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management.

  2016cites this paper
• Bladder metastasis presenting as neck, arm and thorax pain: a case report

  2016cites this paper
• 18 F-fluoride PET/CT in clinical practice PET/CT com fluoreto- 18 F na prática clínica

  2015cites this paper
• Imaging of bone metastasis: An update.

  2015cites this paper
• Diagnostic value of bone-specific alkaline phosphatase in lung carcinoma patients with bone metastases: a meta-analysis.

  2015influential citation
• 18F-fluoride PET/CT in clinical practice

  2015cites this paper
• Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.

  2015cites this paper
• Radiothérapie interne par dichlorure de radium223 : résultats préliminaires

  2015cites this paper
• Use of articulated registration for response assessment of individual metastatic bone lesions

  2014cites this paper
• Diagnostic imaging techniques for diagnosing bone metastases of non-small cell lung cancer

  2014cites this paper
• Prospective Multicenter Study of Bone Scintigraphy in Consecutive Patients With Newly Diagnosed Prostate Cancer

  2014cites this paper
• ЛУЧЕВЫЕ МЕТОДЫ ДИАГНОСТИКИ КОСТНЫХ МЕТАСТАЗОВ НЕМЕЛКОКЛЕТОЧНОГО РАКА ЛЁГКОГО

  2014cites this paper
• Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group.

  2014influential citation
• Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

  2014cites this paper
• Whole-Body 18F-Fluorocholine (FCH) PET/CT and MRI of the Spine for Monitoring Patients With Castration-Resistant Prostate Cancer Metastatic to Bone: A Pilot Study

  2014cites this paper
• Basic Premises to Molecular Imaging and Radionuclide Therapy - Part 1

  2014cites this paper
• Skeletal SPECT/CT: a review

  2014cites this paper
• Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease.

  2014cites this paper
• Non-FDG PET studies in oncology : bone PET with fluoride ( 18 F )

  2013influential citation
• Subtotal sternectomy for recurrent breast cancer

  2013cites this paper
• Pain Assessment, Recognising Clinical Patterns, and Cancer Pain Syndromes

  2013cites this paper
• Complementary roles of tumour specific PET tracer 18F-FAMT to 18F-FDG PET/CT for the assessment of bone metastasis

  2013cites this paper
• Bone metastases radiopharmaceuticals: an overview.

  2013cites this paper
• What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?

  2013cites this paper
• [State of the art in nuclear imaging for the diagnosis of bone metastases].

  2013cites this paper
• Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.

  2013cites this paper
• Évolution de la demande des examens de médecine nucléaire pour cancer de la prostate depuis l’enregistrement de la fluorocholine (18F) : analyse sur deux ans à l’hôpital Tenon ☆

  2012cites this paper
• 18F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy

  2012cites this paper
• Na18F PET in oncology

  2012cites this paper
• FDG injection site extravasation: potential pitfall of misinterpretation and missing metastases.

  2012cites this paper
• Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment).

  2012influential citation
• Application of Artificial Intelligence Methods for Imaging of Spinal Metastasis

  year unknowninfluential citation